What to Know About Multiple Sclerosis Progression in Chart Form
A more visual explanation of the progression of MS can be helpful for understanding your symptoms and the type of…
How a Portable Electric Mobility Scooter Can Transform Your Independence
Regain Your Independence with Portable Electric Mobility Scooters Mobility issues can dampen independence and make even the simplest daily tasks…
Stuart Schlossman
Multiple Sclerosis Activism and Healthcare
— In the halls of Congress and in state and local government, we are advocating for accessible, affordable health coverage…
Stuart Schlossman
7 Things ER Doctors Say You Should Always Do After A Fall
Always Do After A Fall Neglecting these crucial steps can actually lead to more serious health problems. By Kelsey Borresen People…
Stuart Schlossman
How to Get Through a Spinal Tap to Confirm an MS Diagnosis
By Ana Sandoiu —– Updated on March 7, 2025Medically Reviewed by: Jason Paul Chua, MD, PhD In many if not…
Stuart Schlossman
Fatigue in MS – a disabling symptom
By Gavin Giovannoni on March 24, 2025 Fatigue in MS is common, but it is often not investigated or managed…
Stuart Schlossman
How MS Affects Your Skin
When Multiple Sclerosis Causes Skin Symptoms Damage to the brain and spinal cord can cause a variety of abnormal sensations…
Stuart Schlossman
Patient Experiences with the Impacts of Multiple Sclerosis & Disease-Modifying Therapies
Bari Talente,1 Lisbet T Finseth,1 Natalie Blake,2 Kathleen Costello,3 Hollie Schmidt,4 Joe Vandigo,5 Elisabeth M Oehrlein5 1National Multiple Sclerosis Society, Washington, DC, USA; 2Multiple Sclerosis Foundation, Fort…
Stuart Schlossman
ACTRIMS 2025: Tolebrutinib impact greater in MS patients with PRLs
Treatment candidate found effective in reducing disability progression risk by Andrea Lobo, PhD | March 5, 2025 — #ACTRIMS Sanofi’s experimental BTK inhibitor tolebrutinib is…
Stuart Schlossman
“Breaking Barriers: The Potential of CAR-T Cell Therapy in Multiple Sclerosis”
CLICK Image to listen to this Round Table discussion…
Stuart Schlossman
